The long-term intravenous (IV) application of OHCbl is impracticable for the patients
COAs and testing records are not medical documents, safety guarantees, sterility guarantees, therapeutic endorsements, dosing guidance, or approval for human or veterinary use.
For best handling, slowly add the bacteriostatic water down the inside wall of the vial rather than directly onto the powder
A provider should consider medical history, medications, pregnancy status, breastfeeding, symptoms, and treatment goals before recommending any peptide-related treatment
Represents procedures performed on neonates and infants up to a present body weight of 4 kilograms